US FDA grants fast track designation to Pfizer’s ervogastat/clesacostat combination to treat NASH
FDA’s decision is informed by the results of Pfizer’s non-clinical studies and a phase-IIa clinical study of…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.